Loading data
PSONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.81 bn USD | 4.45 bn USD | 4.68 bn USD | 4.63 bn USD | 4.64 bn USD |
| Cost of revenue | 1.83 bn USD | 1.72 bn USD | 1.89 bn USD | 2.03 bn USD | 1.93 bn USD |
| Gross profit | 2.99 bn USD | 2.73 bn USD | 2.79 bn USD | 2.6 bn USD | 2.72 bn USD |
| Research and development expense | 10.77 m USD | 7.51 m USD | 10.19 m USD | — | — |
| Selling, general and administrative expense | 1.7 bn USD | 1.45 bn USD | 1.5 bn USD | 1.51 bn USD | 1.61 bn USD |
| Operating profit after depreciation | 608.35 m USD | 630.96 m USD | 615.25 m USD | 418.1 m USD | 400.81 m USD |
| Operating profit before depreciation | 1.29 bn USD | 1.28 bn USD | 1.29 bn USD | 1.09 bn USD | 1.1 bn USD |
| EBIT | 608.35 m USD | 630.96 m USD | 615.25 m USD | 418.1 m USD | 400.81 m USD |
| EBITDA | 1.29 bn USD | 1.28 bn USD | 1.29 bn USD | 1.09 bn USD | 1.1 bn USD |
| Interest expense | 95.56 m USD | 87.63 m USD | 72.61 m USD | 34.94 m USD | 92.08 m USD |
| Profit before tax | 615.08 m USD | 638.47 m USD | 627.98 m USD | 389.18 m USD | 212.59 m USD |
| Income tax expense | 162.85 m USD | 93.89 m USD | 143.94 m USD | 95.19 m USD | -4.06 m USD |
| Income before extraordinary items | 450.88 m USD | 543.33 m USD | 481.5 m USD | 291.59 m USD | 215.3 m USD |
| Net income (reported basis) | 450.88 m USD | 543.33 m USD | 481.5 m USD | 291.59 m USD | 215.3 m USD |
| Basic EPS including extraordinary items | 0.69 USD/share | 0.81 USD/share | 0.68 USD/share | 0.4 USD/share | 0.28 USD/share |
| Diluted EPS including extraordinary items | 0.69 USD/share | 0.79 USD/share | 0.67 USD/share | 0.39 USD/share | 0.28 USD/share |
| Common dividends | 215.34 m USD | 195.3 m USD | 197.44 m USD | 187.96 m USD | 201.76 m USD |
| Total dividends | 215.34 m USD | 195.3 m USD | 197.44 m USD | 187.96 m USD | 201.76 m USD |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.